Capecitabine for the treatment of advanced gastric cancer

Capecitabine for the treatment of advanced gastric cancer

Bibliographic Details
Main Authors:	G Norman, M Soares, P Peura, S Rice, D Suh, K Wright, M Sculpher, A Eastwood
Format:	Article
Language:	English
Published:	NIHR Journals Library 2010-10-01
Series:	Health Technology Assessment
Online Access:	https://doi.org/10.3310/hta14suppl2/02

Similar Items

Cost-effectiveness analysis of capecitabine monotherapy versus capecitabine plus oxaliplatin in elderly patients with advanced gastric cancer.
by: Jingyuan Peng, et al.
Published: (2018-01-01)

Ixabepilone as Monotherapy or in Combination with Capecitabine for the Treatment of Advanced Breast Cancer
by: Katherine H. Rak Tkaczuk
Published: (2011-01-01)

Ixabepilone as Monotherapy or in Combination with Capecitabine for the Treatment of Advanced Breast Cancer
by: Katherine H. Rak Tkaczuk
Published: (2011-01-01)

Efficacy and safety of oxaliplatin and capecitabine in combination with sintilimab as first-line treatment for HER2-negative advanced gastric cancer
by: ZHANG Xiaorui, SHAN Haixia, ZHU Zhengqiu
Published: (2025-01-01)

Capecitabine enhances sensitivity to oxaliplatin in advanced gastric cancer and the effects on patients’ FOXP1 and GGT levels
by: Xinyu Guo, et al.
Published: (2025-01-01)

Capecitabine enhances sensitivity to oxaliplatin in advanced gastric cancer and the effects on patients' FOXP1 and GGT levels
by: Xinyu Guo, et al.
Published: (2024-11-01)

Evaluation of Outcome and Tolerability of Combination Chemotherapy with Capecitabine and Oxaliplatin as First Line Therapy in Advanced Gastric Cancer
by: Mohammad Ali Mashhadi, et al.
Published: (2016-10-01)

Phase I study of imatinib, cisplatin and 5-fluoruracil or capecitabine in advanced esophageal and gastric adenocarcinoma
by: Mayr Martina, et al.
Published: (2012-12-01)

Short-term efficacy and safety of sintilimab combined with oxaliplatin and capecitabine as neoadjuvant therapy for locally advanced gastric cancer
by: ZHANG Shuai, LIU Liangliang, HUANG Di, SHENG Ru, DU Xuetao, LI Shuguang, HU Nan, ZHAO Yifeng
Published: (2025-01-01)

Modified biweekly oxaliplatin and capecitabine for advanced gastric cancer: A retrospective analysis from a medical center
by: Yung-Chia Kuo, et al.
Published: (2014-06-01)

Neoadjuvant Capecitabine and Oxaliplatin Before Concurrent Capecitabine and Radiation in Locally Advanced Rectal Cancers: Experience of a Cancer Hospital in Pakistan
by: Muhammad Atif Mansha, et al.
Published: (2021-12-01)

Neoadjuvant Bevacizumab Plus Docetaxel/Cisplatin/Capecitabine Chemotherapy in Locally Advanced Gastric Cancer Patients: A Pilot Study
by: Deguo Yu, et al.
Published: (2022-05-01)

Effectiveness and safety of capecitabine, irinotecan and panitumumab in advanced colorectal cancer
by: Pui Lam Yip, et al.
Published: (2023-04-01)

Cardiotoxicity induced by capecitabine and oxaliplatin in gastric cancer treatment: a rare case of cardiac arrest and cardiogenic shock
by: Muhammad Umer Riaz Gondal, et al.
Published: (2024-03-01)

CAPECITABINE IN THE TREATMENT OF BRAIN METASTATIC LESION IN PATIENTS WITH BREAST CANCER
by: E. A. Moskvina, et al.
Published: (2015-04-01)

S-1-based chemotherapy versus capecitabine-based chemotherapy as first-line treatment for advanced gastric carcinoma: a meta-analysis.
by: Ming-ming He, et al.
Published: (2013-01-01)

A Pilot Study of the Combination of Entinostat with Capecitabine in Advanced Breast Cancer
by: Trish Millard, et al.
Published: (2024-01-01)

Multidisciplinary approach to the management of capecitabine-associated hand foot syndrome in cancer patients receiving capecitabine plus oxaliplatin and bevacizumab for advanced colorectal cancer
by: Hiroshi Matsuoka, et al.
Published: (2017-02-01)

Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study
by: Anchuan Li, et al.
Published: (2022-07-01)

A Phase I study of pevonedistat plus capecitabine plus oxaliplatin in patients with advanced gastric cancer refractory to platinum (NCCH-1811)
by: Hirokazu Shoji, et al.
Published: (2021-08-01)

S-1 plus oxaloplatin (S-1OX) versus capecitabine plus oxaloplatin (CAPOX) for advanced gastric cancer: A systematic review and meta-analysis
by: S.M.Zeeshan Qadar, et al.
Published: (2024-01-01)

Comparative outcome of cisplatin-capecitabine regimen with oxaliplatincapecitabine regimen in advanced gastric carcinoma: a quasi-experimental study
by: Mohammad Jahan Shams, et al.
Published: (2023-01-01)

Clinical Management of Localized Colon Cancer with Capecitabine
by: J. Quidde, et al.
Published: (2012-11-01)

Clinical Management of Localized Colon Cancer with Capecitabine
by: J. Quidde, et al.
Published: (2012-01-01)

Helical tomotherapy with concurrent capecitabine for the treatment of inoperable pancreatic cancer
by: Kang Young-Nam, et al.
Published: (2010-06-01)

Complete response in advanced breast cancer patient treated with a combination of capecitabine, oral vinorelbine and dasatinib
by: V. Sgroi, et al.
Published: (2018-01-01)

Ileitis Secondary to Oral Capecitabine Treatment?
by: Rami Radwan, et al.
Published: (2012-01-01)

Response of Cutaneous Metastases from Breast Cancer to Capecitabine
by: Kostandinos Sideras, et al.
Published: (2008-01-01)

Lapatinib and capecitabine as third-line therapy in young woman with advanced breast cancer
by: Michela Donadio
Published: (2018-06-01)

Capecitabine/irinotecan combination regimens in colorectal cancer.
by: Kerr, D
Published: (2002)

Metronomic capecitabine versus doxorubicin in advanced hepatocellular carcinoma
by: Gehan Abd Elatti Khedr, et al.
Published: (2016-06-01)

A pathological complete response to capecitabine plus oxaliplatin regimen combined with tislelizumab in advanced gastric cancer with liver metastases: A case report
by: Li-Ping Sheng, et al.
Published: (2024-12-01)

A Phase Ib/II Study Evaluating the Combination of Weekly Docetaxel and Cisplatin Together with Capecitabine and Bevacizumab in Patients with Advanced Esophago-Gastric Cancer.
by: Baruch Brenner, et al.
Published: (2016-01-01)

The Clinical Efficacy and Safety of Neratinib in Combination with Capecitabine for the Treatment of Adult Patients with Advanced or Metastatic HER2-Positive Breast Cancer
by: Chilà G, et al.
Published: (2021-06-01)

Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial.
by: Madi, A, et al.
Published: (2012)

Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: The MRC COIN trial
by: Madi, A, et al.
Published: (2012)

Capecitabine-Associated Terminal Ileitis
by: Irene E.G. van Hellemond, et al.
Published: (2018-10-01)

Thymidine Phosphorylase/β-tubulin III expressions predict the response in Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel
by: Shen Lin, et al.
Published: (2011-05-01)

Capecitabine and Temozolomide (CAPTEM) in Advanced Neuroendocrine Neoplasms (NENs): A Systematic Review and Pooled Analysis
by: Arrivi G, et al.
Published: (2022-12-01)

Adherence and safety study in patients on treatment with capecitabine
by: Francisca Fernández-Ribeiro, et al.
Published: (2017-03-01)